These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 22513881)

  • 1. α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease.
    Lastres-Becker I; Ulusoy A; Innamorato NG; Sahin G; Rábano A; Kirik D; Cuadrado A
    Hum Mol Genet; 2012 Jul; 21(14):3173-92. PubMed ID: 22513881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of α-synuclein aggregation and the nuclear factor E2-related factor 2/heme oxygenase-1 pathway in iron-induced neurotoxicity.
    He Q; Song N; Jia F; Xu H; Yu X; Xie J; Jiang H
    Int J Biochem Cell Biol; 2013 Jun; 45(6):1019-30. PubMed ID: 23454680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's Disease.
    Lastres-Becker I; García-Yagüe AJ; Scannevin RH; Casarejos MJ; Kügler S; Rábano A; Cuadrado A
    Antioxid Redox Signal; 2016 Jul; 25(2):61-77. PubMed ID: 27009601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
    Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.
    Rojo AI; Innamorato NG; Martín-Moreno AM; De Ceballos ML; Yamamoto M; Cuadrado A
    Glia; 2010 Apr; 58(5):588-98. PubMed ID: 19908287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte-specific overexpression of Nrf2 delays motor pathology and synuclein aggregation throughout the CNS in the alpha-synuclein mutant (A53T) mouse model.
    Gan L; Vargas MR; Johnson DA; Johnson JA
    J Neurosci; 2012 Dec; 32(49):17775-87. PubMed ID: 23223297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of Nrf2-ARE activator isolated from green perilla leaves on dopaminergic neuronal loss in a Parkinson's disease model.
    Masaki Y; Izumi Y; Matsumura A; Akaike A; Kume T
    Eur J Pharmacol; 2017 Mar; 798():26-34. PubMed ID: 28167258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1.
    Innamorato NG; Jazwa A; Rojo AI; García C; Fernández-Ruiz J; Grochot-Przeczek A; Stachurska A; Jozkowicz A; Dulak J; Cuadrado A
    PLoS One; 2010 Jul; 5(7):e11838. PubMed ID: 20676377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.
    Thome AD; Standaert DG; Harms AS
    PLoS One; 2015; 10(10):e0140566. PubMed ID: 26469270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2-ARE signals mediated the anti-oxidative action of electroacupuncture in an MPTP mouse model of Parkinson's disease.
    Lv E; Deng J; Yu Y; Wang Y; Gong X; Jia J; Wang X
    Free Radic Res; 2015; 49(11):1296-307. PubMed ID: 26118717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kavalactone derivative inhibits lipopolysaccharide-stimulated iNOS induction and NO production through activation of Nrf2 signaling in BV2 microglial cells.
    Terazawa R; Akimoto N; Kato T; Itoh T; Fujita Y; Hamada N; Deguchi T; Iinuma M; Noda M; Nozawa Y; Ito M
    Pharmacol Res; 2013 May; 71():34-43. PubMed ID: 23419834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant.
    Hoenen C; Gustin A; Birck C; Kirchmeyer M; Beaume N; Felten P; Grandbarbe L; Heuschling P; Heurtaux T
    PLoS One; 2016; 11(9):e0162717. PubMed ID: 27622765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis.
    Lastres-Becker I; Innamorato NG; Jaworski T; Rábano A; Kügler S; Van Leuven F; Cuadrado A
    Brain; 2014 Jan; 137(Pt 1):78-91. PubMed ID: 24277722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells.
    Foresti R; Bains SK; Pitchumony TS; de Castro Brás LE; Drago F; Dubois-Randé JL; Bucolo C; Motterlini R
    Pharmacol Res; 2013 Oct; 76():132-48. PubMed ID: 23942037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway.
    Huang TT; Hao DL; Wu BN; Mao LL; Zhang J
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1443-1449. PubMed ID: 28986252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
    Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
    FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease.
    Van der Perren A; Macchi F; Toelen J; Carlon MS; Maris M; de Loor H; Kuypers DR; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V
    Neurobiol Aging; 2015 Mar; 36(3):1559-68. PubMed ID: 25660193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.